Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 23, 2009 08:00 ET | Source: BSD Medical Corporation

BSD Medical Corporation -- Tacoma/Valley Radiation Oncology Centers Provide New Cancer Treatment in Pacific Northwest With Acquisition of BSD-500 Hyperthermia System

TACOMA, Wash., April 23, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) is pleased to announce that the Tacoma/Valley Radiation Oncology Centers in Tacoma, Washington, have become the...
April 17, 2009 08:05 ET | Source: BSD Medical Corporation

BSD Medical: TV News Coverage Reports On the Use of Hyperthermia to Treat Recurrent Cancers

SALT LAKE CITY, April 17, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) today reported that hyperthermia treatment was highlighted in a television segment that aired on WKYC, Channel 3,...
April 15, 2009 08:00 ET | Source: BSD Medical Corporation

BSD Medical: Clinical Study Using Hyperthermia Combined With Chemotherapy to Treat Children and Adolescents Shows Promise

SALT LAKE CITY, April 15, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) today reported on clinical data presented by Rudiger Wessalowski, M.D, Associate Professor at the Clinic of Pediatric...
April 14, 2009 08:05 ET | Source: BSD Medical Corporation

BSD Medical: Evolving Role of Clinical Hyperthermia Reviewed At Society for Thermal Medicine Annual Meeting

SALT LAKE CITY, April 14, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) today reported on a review of the evolving role of hyperthermia titled, "Current Status of Clinical Trials for Cancer...
April 07, 2009 18:34 ET | Source: BSD Medical Corporation

BSD Medical Names Harold R. Wolcott as New President and Board Member

SALT LAKE CITY, April 7, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today announced that Harold R. Wolcott, an accomplished executive with extensive experience in the medical...
March 31, 2009 08:00 ET | Source: BSD Medical Corporation

BSD Medical Corporation: Hyperthermia Therapy Contributes to Improved Tumor Control and Survival Rate for Esophageal Cancer Patients

SALT LAKE CITY, March 31, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today announced that a report titled "Preoperative chemoradiation combined with regional hyperthermia for...
March 26, 2009 08:05 ET | Source: BSD Medical Corporation

BSD Medical Corp.: Paul F. Turner Receives 2009 Distinguished Alumnus Award From University of Utah

SALT LAKE CITY, March 26, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) is pleased to announce that Paul F. Turner, the company's Chief Technology Officer, Sr. VP and Chairman of the Board,...
March 12, 2009 08:00 ET | Source: BSD Medical Corporation

BSD Medical Corp.: Lecture At Surgical Oncology Conference Reports Near Doubling of Disease-Free Survival When Hyperthermia Therapy Was Added to Chemotherapy in Treating Sarcoma Cancer Patients

SALT LAKE CITY, March 12, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) announced today that Professor Rolf Issels, M.D. Ph.D. of the Munich University Medical School in Germany delivered...
March 05, 2009 13:03 ET | Source: BSD Medical Corporation

BSD Files Humanitarian Use Petition With FDA for Marketing Approval for the BSD-2000 Hyperthermia System

SALT LAKE CITY, March 5, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) announced today that the company has filed a Humanitarian Use Device Petition for the BSD-2000 Hyperthermia...
March 03, 2009 12:07 ET | Source: BSD Medical Corporation

BSD Medical Exhibits At 2009 American College of Radiation Oncology Conference

SALT LAKE CITY, March 3, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) today reported on the company's attendance and exhibition at the ACRO (American College of Radiation Oncology) annual...

Next Page keyboard_arrow_right